Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases

Table 1 Serum IGF-1, osteocalcin and PTH levels in patient groups and control group (mean ± SE)

	Control	Bilharziasis	HBV	HCV
	(n = 30)	(n = 9)	(n = 12)	(n = 29)
IGF-1 (ng/mL)	277.1 ± 12.2	94.0 ± 4.30b	105.1± 10.3b	230.0 ± 10.5b
Osteocalcin (ng/mL)	5.7 ± 0.3	6.8 ± 0.66	16.5 ± 0.76b	14.7 ± 0.54b
PTH (ng/mL)	61.6 ± 2.7	63.3 ± 3.03	83.4 ± 4.30b	70.1 ± 2.17a

^aP < 0.05,

^bP < 0.01 vs control group.